ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,297Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 80

$1.24M Total Retail Price of All Prescriptions

Rank: 3 out of 80

906 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 906 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 19,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 37%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $87 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
AMLODIPINE BESYLATE 1,283 1,209 1 2
LOSARTAN POTASSIUM 1,195 1,101 2 1
SIMVASTATIN 1,170 1,081 3 3
OMEPRAZOLE 855 696 4 9
ATORVASTATIN CALCIUM 793 734 5 5
METOPROLOL SUCCINATE 669 629 6 11
METFORMIN HCL ER 591 497 7 41
PRAVASTATIN SODIUM 570 519 8 13
LISINOPRIL 570 505 8 4
LOSARTAN-HYDROCHLOROTHIAZIDE 567 530 10 22
GLIPIZIDE ER 425 394 10 11 42
DIOVAN 417 366 12 17
LEVOTHYROXINE SODIUM 411 353 13 6
FUROSEMIDE 353 320 14 10
CRESTOR 343 290 15 31
CLONIDINE HCL 296 264 16 107
ALENDRONATE SODIUM 294 276 17 12
LOVASTATIN 285 221 18 7
PANTOPRAZOLE SODIUM 281 264 19 45
CLOPIDOGREL 277 255 20 36
ALLOPURINOL 277 244 20 14
TAMSULOSIN HCL 242 224 22 47
AZITHROMYCIN 237 204 23 56
RANITIDINE HCL 221 174 24 40
CEFDINIR 214 194 25 133
GLIMEPIRIDE 210 187 26 34
MECLIZINE HCL 209 206 27 93
FELODIPINE ER 208 208 28 21
PLAVIX 206 195 29 63
TRAMADOL HCL 203 182 30 58
ACTOS 202 192 31 77
DIOVAN HCT 197 188 32 65
JANUVIA 189 172 33 23
CLOTRIMAZOLE-BETAMETHASONE 165 130 34 154
PREDNISONE 161 129 35 15
COLCRYS 151 137 36 44
EVISTA 148 138 37 18
CARVEDILOL 142 108 38 33
PROAIR HFA 141 122 39 137
POTASSIUM CHLORIDE 139 103 40 38
SPIRIVA 139 134 40 92
WARFARIN SODIUM 128 97 42 46
ADVAIR DISKUS 123 108 43 72
NIFEDIPINE ER 118 107 44 75
VENTOLIN HFA 117 100 45 123
NAMENDA 111 101 46 27
DIGOXIN 106 88 47 48
SINGULAIR 102 63 48 206
ATENOLOL 98 90 49 29
METFORMIN HCL 95 71 50 8
SYMBICORT 94 92 51 215
METOPROLOL TARTRATE 92 75 52 20
JANUMET 92 79 52 100
MUPIROCIN 88 60 54 102
HYDROCHLOROTHIAZIDE 85 73 55 16
DONEPEZIL HCL 83 77 56 32
LANTUS SOLOSTAR 83 40 56 39
BENICAR 80 74 58 119
LIPITOR 80 78 58 67
HYDROCODONE-ACETAMINOPHEN 79 66 S3 60 30
LACTULOSE 76 30 61 60
GLIPIZIDE XL 75 64 62 118
ACTONEL 70 70 63 79
ISOSORBIDE MONONITRATE ER 69 69 64 242
PIOGLITAZONE HCL 69 62 R 64 183
PRADAXA 67 63 66 184
ZOLPIDEM TARTRATE 66 50 67 74
FENOFIBRATE 65 37 68 73
SINGLE USE SWAB 64 38 69 253
AMLODIPINE BESYLATE-BENAZEPRIL 64 35 69 53
VOLTAREN 61 60 71 168
CLOBETASOL PROPIONATE 61 54 71 86
PEN NEEDLE 61 38 71 50
GENERLAC 60 23 74 260
SPIRONOLACTONE 58 54 75 142
TRIAMCINOLONE ACETONIDE 58 43 75 62
CEPHALEXIN 58 46 75 187
CIPROFLOXACIN HCL 56 48 78 69
NIFEDIAC CC 56 55 78 122
LYRICA 56 50 78 80
FINASTERIDE 55 55 81 119
ONGLYZA 55 39 81 134
VERAPAMIL ER 54 45 83 147
PROMETHAZINE-CODEINE 54 50 R 83 140
MONTELUKAST SODIUM 53 36 85 280
VALSARTAN-HYDROCHLOROTHIAZIDE 53 50 85 198
FLOVENT HFA 50 30 87 150
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.